WSV-12158-91116
1 vaccination
8 coded responses
14 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 782 / TX
- Registered
- 2021-09-21
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-21
Registered in v-safe
-
2021-09-21
Dose 1 — Janssen/Johnson & Johnson
-
2021-09-21
Survey response — day 0, dose 1MedDRA: Hypoaesthesia — Feeling: Good · Site: PainFree text: Numbness to right armMedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Survey response — days 1–6 daily, dose 1MedDRA: Musculoskeletal stiffness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Neck stiffnessMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2021-09-24
Survey response — days 1–6 daily, dose 1MedDRA: Abnormal menstrual clots, Menstruation irregular — Feeling: Fair · Site: Pain, SwellingFree text: Menstrual cycle irregularities. Started early and with lots of clotsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-25
Survey response — days 1–6 daily, dose 1MedDRA: Abnormal menstrual clots — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Lots of clotting with menstrual cycleMedDRA releases: 2024-11 · check-in free text available
-
2021-09-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-09-28
- 2021-10-05
- 2021-10-21
-
2021-10-28
Survey response — day 35, single doseMedDRA: Fatigue, Menstruation irregular — Feeling: Fair · Be unable to work or attend schoolFree text: Increased fatigue. Late menstrual and irregular cycleMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — 3 months, dose 1MedDRA: Cough, Malaise — Feeling: FairFree text: Cough MalaiseMedDRA releases: 2024-11 · check-in free text available
-
2022-03-22
Survey response — 6 months, dose 1MedDRA: Arthralgia, Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle and joint aches, increased fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Survey response — 12 months, dose 1MedDRA: Fatigue, Sinusitis, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Repeated virus' including sinus infections etc. prolonged fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-21 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-21 | Unsuccessful |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Numbness to right arm
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Neck stiffness
Systemic reaction (other): Menstrual cycle irregularities. Started early and with lots of clots
Systemic reaction (other): Lots of clotting with menstrual cycle
Release 10 — day 35, single dose
Symptoms: Increased fatigue. Late menstrual and irregular cycle
Release 10 — 3 months, dose 1
Symptoms: Cough Malaise
Release 11 — 6 months, dose 1
Symptoms: Muscle and joint aches, increased fatigue
Release 12 — 12 months, dose 1
Symptoms: Repeated virus' including sinus infections etc. prolonged fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Abnormal menstrual clots | · | · | ✓ |
| SRO | Hypoaesthesia | · | · | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
| SRO | Musculoskeletal stiffness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release